Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 13, 2026

AstraZeneca Baxdrostat Gains EU Backing

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 13, 2026

AstraZeneca Baxdrostat Gains EU Backing

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 13, 2026

Generate Biomedicines Lands $1.2B Zealand Deal

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 13, 2026

Generate Biomedicines Lands $1.2B Zealand Deal

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 12, 2026

FDA Target Dates Sharpen Biotech Catalyst Risk

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 12, 2026

FDA Target Dates Sharpen Biotech Catalyst Risk

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 11, 2026

NRx Pharmaceuticals Launches Ketamine

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 11, 2026

NRx Pharmaceuticals Launches Ketamine

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 11, 2026

Cullinan Phase 3 Win Supports Zipalertinib Filing

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 11, 2026

Cullinan Phase 3 Win Supports Zipalertinib Filing

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 10, 2026

Fate Therapeutics Tests Conditioning-Free Cell Therapy

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 10, 2026

Fate Therapeutics Tests Conditioning-Free Cell Therapy

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 10, 2026

Windward Bio Tests Biotech IPO Appetite

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 10, 2026

Windward Bio Tests Biotech IPO Appetite

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 9, 2026

AchieveRx NDA Advances Smoking-Cessation Drug

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 9, 2026

AchieveRx NDA Advances Smoking-Cessation Drug

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 9, 2026

Vir Biotechnology’s Hepatitis D Win

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 9, 2026

Vir Biotechnology’s Hepatitis D Win

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 8, 2026

Cabaletta Bio Data Advance Autoimmune Cell Therapy

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 8, 2026

Cabaletta Bio Data Advance Autoimmune Cell Therapy

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 8, 2026

Arrowhead Data Strengthens RNAi Case

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 8, 2026

Arrowhead Data Strengthens RNAi Case

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 7, 2026

J&J’s Icotrokinra Raises PsA Bar

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 7, 2026

J&J’s Icotrokinra Raises PsA Bar

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 7, 2026

Moderna Guidance Lift Reframes Biotech

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 7, 2026

Moderna Guidance Lift Reframes Biotech

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 6, 2026

J&J Approval Raises Oncology Bar

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 6, 2026

J&J Approval Raises Oncology Bar

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 5, 2026

Kairos Pharma Data Lift Prostate Pipeline

Pipette dispensing pink liquid into lab sample tubes

POST DATE

November 5, 2026

Kairos Pharma Data Lift Prostate Pipeline

HudsonAlpha Visit Signals US Biotech Security Focus

POST DATE

May 5, 2026

HudsonAlpha Visit Signals US Biotech Security Focus

HudsonAlpha Visit Signals US Biotech Security Focus

POST DATE

May 5, 2026

HudsonAlpha Visit Signals US Biotech Security Focus

POST DATE

March 12, 2026

Merck's Keytruda Wins FDA Approval for New Gastric Cancer Indication, Boosting Oncology Pipeline

POST DATE

March 12, 2026

Merck's Keytruda Wins FDA Approval for New Gastric Cancer Indication, Boosting Oncology Pipeline

Biotech Rally Meets Sharper Clinical, Regulatory Risk Test

POST DATE

November 5, 2026

Biotech Rally Meets Sharper Clinical, Regulatory Risk Test

Biotech Rally Meets Sharper Clinical, Regulatory Risk Test

POST DATE

November 5, 2026

Biotech Rally Meets Sharper Clinical, Regulatory Risk Test

Axsome (AXSM) Q3 Growth Strengthens Commercial Biotech Case

POST DATE

November 4, 2026

Axsome (AXSM) Q3 Growth Strengthens Commercial Biotech Case

Axsome (AXSM) Q3 Growth Strengthens Commercial Biotech Case

POST DATE

November 4, 2026

Axsome (AXSM) Q3 Growth Strengthens Commercial Biotech Case

Pfizer Oncology Updates Boost Platform-Based Growth Case

POST DATE

November 3, 2026

Pfizer Oncology Updates Boost Platform-Based Growth Case

Pfizer Oncology Updates Boost Platform-Based Growth Case

POST DATE

November 3, 2026

Pfizer Oncology Updates Boost Platform-Based Growth Case

FDA Approves Generic Lenacapavir for HIV Prevention

POST DATE

November 3, 2026

FDA Approves Generic Lenacapavir for HIV Prevention

FDA Approves Generic Lenacapavir for HIV Prevention

POST DATE

November 3, 2026

FDA Approves Generic Lenacapavir for HIV Prevention

GSK's Jemperli Wins Accelerated FDA Approval

POST DATE

November 2, 2026

GSK's Jemperli Wins Accelerated FDA Approval

GSK's Jemperli Wins Accelerated FDA Approval

POST DATE

November 2, 2026

GSK's Jemperli Wins Accelerated FDA Approval

Inovio Approval Meets Bright Minds Setback in Biotech Divide

POST DATE

November 2, 2026

Inovio Approval Meets Bright Minds Setback in Biotech Divide

Inovio Approval Meets Bright Minds Setback in Biotech Divide

POST DATE

November 2, 2026

Inovio Approval Meets Bright Minds Setback in Biotech Divide

INOVIO (INO) Wins FDA Approval for VOCERYQ

POST DATE

November 1, 2026

INOVIO (INO) Wins FDA Approval for VOCERYQ

INOVIO (INO) Wins FDA Approval for VOCERYQ

POST DATE

November 1, 2026

INOVIO (INO) Wins FDA Approval for VOCERYQ

Growth Picks

Discover the latest market trends as they unfold.

NEVER MISS A THING!

Subscribe and get our latest Ticker updates. Join the community!

Join the newsletter to receive the latest updates in your inbox.

NEVER MISS A Trend

Access premium content for just $5/month. Enjoy exclusive news and articles with your subscription.

Unlock a world of insightful analysis, expert opinions, and in-depth articles designed to keep you ahead in the market. With your monthly subscription, you'll gain exclusive access to content that delves deep into the latest trends, top tickers, and strategic insights. Join today and elevate your financial knowledge.

NEVER MISS A Trend

Access premium content for just $5/month. Enjoy exclusive news and articles with your subscription.

Unlock a world of insightful analysis, expert opinions, and in-depth articles designed to keep you ahead in the market. With your monthly subscription, you'll gain exclusive access to content that delves deep into the latest trends, top tickers, and strategic insights. Join today and elevate your financial knowledge.

NEVER MISS A Trend

Access premium content for just $5/month. Enjoy exclusive news and articles with your subscription.

Unlock a world of insightful analysis, expert opinions, and in-depth articles designed to keep you ahead in the market. With your monthly subscription, you'll gain exclusive access to content that delves deep into the latest trends, top tickers, and strategic insights. Join today and elevate your financial knowledge.


Discover the future of investing with BullishDaily, your ultimate destination for insightful stock analysis and market intelligence. Whether you’re a seasoned investor or just starting your financial journey, BullishDaily provides in-depth coverage of the latest market trends, top-performing stocks, and emerging investment opportunities.


Our expert analysis goes beyond the headlines to deliver actionable insights, helping you make informed decisions in a rapidly changing market. From tech giants and blue-chip stocks to innovative startups and niche markets, BullishDaily keeps you ahead of the curve with comprehensive reports, expert opinions, and strategic investment ideas.


Stay empowered with BullishDaily as your trusted resource for navigating the complexities of the stock market. Join us on the path to financial success with timely updates, thought-provoking articles, and a community of like-minded investors. At BullishDaily, we bring you the knowledge and tools you need to grow your portfolio and achieve your investment goals

COPYRIGHT © Bullish Daily

BullishDaily